| abstract |
The patent application provides monoclonal antibodies that specifically bind to hemagglutinin of avian influenza virus subtype H5, as well as monoclonal antibodies that can block at least 50% of hemagglutinin binding activity. Such antibodies are useful, for example, in the detection, diagnosis, prevention, and treatment of avian influenza viruses. Also provided herein are hybridoma cell lines, isolated nucleic acid molecules, and short peptides for the monoclonal antibodies provided herein, and pharmaceutical compositions and kits comprising the monoclonal antibodies provided herein. . |